Philip R. Wyde

Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors

Todd Trask, Rebecca P. Trask, Estuardo Aguilar-Córdova et al. · Molecular Therapy · 2000 · 263 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice

Morteza Naghavi, Philip R. Wyde, Silvio Litovsky et al. · Circulation · 2003 · 243 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

Philip R. Wyde, Srikrishna N. Chetty, Alan M. Jewell et al. · Antiviral Research · 2003 · 219 citations

Life Sciences, Infectious Diseases, Pharmacokinetics +12

Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised Adults

Janet A. Englund, R. Champlin, Philip R. Wyde et al. · Clinical Infectious Diseases · 1998 · 162 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Genetic Inactivation of an Extracellular Cysteine Protease (SpeB) Expressed by<i>Streptococcus pyogenes</i>Decreases Resistance to Phagocytosis and Dissemination to Organs

Eugene H. Burns, Philip R. Wyde, Andreas Podbielski et al. · Infection and Immunity · 1998 · 132 citations · Full text

Life Sciences, Immunology, Microbiology +17